The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

23 May 2018 16:16

RNS Number : 0841P
Medica Group PLC
23 May 2018
 

 

23 May 2018

Medica Group Plc

 

Result of Annual General Meeting

 

Medica Group Plc (LSE: MGP, "Medica" or the "Company") announces that, at its Annual General Meeting held at the offices of Eversheds Sutherlands (International) LLP at One Wood Street, London at 10.00 a.m. today, all resolutions put to the meeting were duly passed.

 

Resolutions

For (including discretionary votes)

% of votes

Against

% of votes cast

Votes cast as a % of relevant shares in issue

Ordinary business

1

To receive and adopt the annual report and accounts of the Company and its subsidiaries for the year ended 31 December 2017

90,012,191

99.61

355,452

0.39

81.33

2

To re-appoint Grant Thornton UK LLP as auditors to the Company

90,077,229

99.68

290,413

0.32

81.33

3

To authorise the Directors to determine the remuneration of the auditors of the Company

90,366,342

99.99

1,301

0.01

81.33

4

To declare a final dividend for the year ended 31 December 2017 of 1.1p per ordinary share

90,367,643

100

-

-

81.33

5

To approve the Directors' Remuneration Report (other than the part containing the Directors' Remuneration Policy) for the year ended 31 December 2017

48,860,702

54.07

41,498,640

45.93

81.32

5A

To approve the Directors' Remuneration Policy in the form set out in the Directors' Remuneration Report

89,681,853

99.25

677,489

0.75

81.32

Special business

6

General authority to allot shares pursuant to Section 551 Companies Act 2006

90,094,299

99.99

8,398

0.01

81.09

7*

Disapplication of pre-emption rights (5% general authority)

79,380,605

87.84

10,987,038

12.16

81.33

8*

Disapplication of pre-emption rights (5% additional authority for an acquisition or specified capital investment)

79,103,170

87.53

11,264,472

12.47

81.33

9*

Authority for on-market purchases of up to 10% of issued share capital

90,089,208

99.69

278,434

0.31

81.33

10*

Authority to call general meetings at 14 clear days' notice

90,201,804

99.82

165,839

0.18

81.33

11

Approve the rules of the Medica Group PLC Company Share Option Plan 2018

89,683,891

99.25

675,451

0.75

81.32

 

* Passed as a special resolution of the Company; all other resolutions were passed as ordinary resolutions of the Company.

 

N.B. Percentage of Votes cast excludes withheld votes. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes validly cast.

 

The Board is pleased to have received shareholder support for all the resolutions proposed at the AGM. The Remuneration Policy was passed with 99% votes in favour. However, the Company recognises the lower level of support it has received for the advisory vote on its Directors' Remuneration Report.

 

The Company's Remuneration Committee, which is keen to foster an open and transparent approach to remuneration, spent a significant amount of time during the period (including before the IPO) in finalising executive remuneration arrangements to ensure these were appropriate for Medica and reflected best practice.

 

The Remuneration Committee understands that the votes against are attributable, in large part, to concerns regarding the level of disclosure in relation to the LTIP targets. Medica is committed to providing a level of disclosure that is acceptable to shareholders. The Board have reflected on the comments received from shareholders and whilst it was always the intention to publish the targets at the conclusion of the performance period, we now expect to bring this forward and publish the targets for the previous year in the relevant Annual Report. This will commence from next year's report which will include the performance criteria for the 2017 and 2018 award.

 

The number of Ordinary Shares in issue on 23 May 2018 at 10.00 a.m. was 111,111,114. Shareholders are entitled to one vote per share.

 

The full text of the resolutions can be found in the Notice of AGM on the Company's website (www.medicagroup.co.uk).

 

A copy of this announcement will shortly be available for inspection at the National Storage Mechanism document viewing facility at www.morningstar.co.uk/uk/NSM.

 

Enquiries:

 

Medica Group:

+44 (0)33 33 111 222

John Graham, Chief Executive Officer

Tony Lee, Chief Financial Officer

Investec Bank plc

+44 (0)20 7597 5970

Sara Hale

Daniel Adams

Henry Reast

Edward Thomas

David Herring

FTI Consulting

+44 (0)20 3727 1000

Brett Pollard

Ben Atwell

Victoria Foster Mitchell

Robert Winder

 

About Medica

 

Medica is the UK market leader by revenue in the provision of teleradiology services, providing outsourced interpretation and reporting on MRI (magnetic resonance imaging), CT (computerised tomography) and plain film (x-ray) images. The Company currently offers three primary services to hospital radiology departments: NightHawk, an out-of-hours service, routine cross-sectional (Routine CS) reporting on MRI and CT scans, and routine plain film (Routine PF) reporting on x-ray images.

 

Medica has developed a bespoke secure IT platform that provides market-leading linkage between a hospital's Radiology Information System (RIS) and Consultant Radiologists who contract with Medica. Direct RIS access ensures that the full wider patient information is available and reviewed with every report.

 

The Company contracts with the largest pool of consultant radiologists outside of the NHS and has been trusted to provide more than 1.5 million examinations annually across its customer base of more than 100 NHS Trusts and various private hospital groups and diagnostic imaging companies. For more information please visit www.medicagroup.co.uk 

 

About teleradiology

 

Teleradiology is the electronic transmission of radiological patient images, including plain film (x-rays), CT scans and MRI scans, from one location to another for the purposes of diagnostic interpretation and reporting.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGEASSDAFLPEFF
Date   Source Headline
28th May 20213:27 pmRNSDirector/PDMR Shareholding
28th May 20212:43 pmRNSDirector/PDMR Shareholding
25th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
11th May 20217:10 amRNSNon-Executive Director Change
11th May 20217:10 amRNSResults for the year ended 31 December 2020
20th Apr 20219:30 amRNSHolding(s) in Company
16th Apr 20219:47 amRNSHolding(s) in Company
29th Mar 202110:48 amRNSHolding(s) in Company
25th Mar 20218:05 amRNSCompletion of Acquisition & Director/PDMR Dealings
23rd Mar 20219:31 amRNSCorrection: Results of Fundraise and TVR
23rd Mar 20217:00 amRNSResults of Fundraise and Total Voting Rights
23rd Mar 20217:00 amRNSRe-release: Proposed acquisition of US-based RadMD
22nd Mar 20215:07 pmRNSProposed Fundraise to raise approximately £16m
22nd Mar 20215:07 pmRNSProposed acquisition of US-based RadMD
19th Mar 20217:00 amRNSMicrosoft Research’s Dr Junaid Bajwa joins as NED
22nd Feb 20217:00 amRNSMedica and Integral Diagnostics establish JV, MedX
11th Feb 202110:09 amRNSHolding(s) in Company
29th Jan 20219:02 amRNSHolding(s) in Company
26th Jan 20217:00 amRNSAppointment of Liberum as Joint Corporate Broker
21st Jan 20217:00 amRNSTrading Update
18th Jan 20217:00 amRNSDr. Robert Lavis appointed Group Medical Director
4th Dec 202011:57 amRNSDirector/PDMR Shareholding
2nd Dec 20209:31 amRNSDirector/PDMR Shareholding
1st Dec 20209:34 amRNSHolding(s) in Company
18th Nov 20204:41 pmRNSSecond Price Monitoring Extn
18th Nov 20204:36 pmRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSDirector/PDMR Shareholding
11th Nov 202012:41 pmRNSHolding(s) in Company
10th Nov 20201:56 pmRNSHolding(s) in Company
6th Nov 20202:26 pmRNSHolding(s) in Company
5th Nov 20207:00 amRNSDirector/PDMR Shareholding
4th Nov 20207:00 amRNSMedica acquires Global Diagnostics Ireland
27th Oct 20209:20 amRNSHolding(s) in Company
22nd Oct 20209:41 amRNSHolding(s) in Company
16th Oct 202011:26 amRNSHolding(s) in Company
7th Oct 202012:34 pmRNSHolding(s) in Company
16th Sep 20201:07 pmRNSDeclaration of Dividend
14th Sep 20207:00 amRNSInterim results demonstrate resilient performance
9th Sep 202010:36 amRNSHolding(s) in Company
25th Aug 20204:41 pmRNSSecond Price Monitoring Extn
25th Aug 20204:36 pmRNSPrice Monitoring Extension
14th Aug 20209:56 amRNSHolding(s) in Company
21st Jul 202010:49 amRNSHolding(s) in Company
8th Jul 20207:00 amRNSTrading Update
11th Jun 20203:22 pmRNSDirector/PDMR Shareholding
1st Jun 20204:54 pmRNSIssue of Equity
28th May 202010:14 amRNSHolding(s) in Company
21st May 202012:55 pmRNSHolding(s) in Company
20th May 20204:25 pmRNSResult of AGM
20th May 20207:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.